Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C21H29Cl2N3O2.C4H4O4 |
Molecular Weight | 968.832 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.NC1=C(Cl)C=C(C=C1Cl)[C@@H](O)CNCCCCCCOCCC2=NC=CC=C2.NC3=C(Cl)C=C(C=C3Cl)[C@@H](O)CNCCCCCCOCCC4=NC=CC=C4
InChI
InChIKey=MZHXOYZUNRCUCP-MMSVOLSESA-N
InChI=1S/2C21H29Cl2N3O2.C4H4O4/c2*22-18-13-16(14-19(23)21(18)24)20(27)15-25-9-4-1-2-6-11-28-12-8-17-7-3-5-10-26-17;5-3(6)1-2-4(7)8/h2*3,5,7,10,13-14,20,25,27H,1-2,4,6,8-9,11-12,15,24H2;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*20-;/m00./s1
Molecular Formula | C21H29Cl2N3O2 |
Molecular Weight | 426.38 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C4H4O4 |
Molecular Weight | 116.0722 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Picumeterol (GR114297A) is a potent and highly selective beta2-adrenoceptor agonist with a longer duration of action than salbutamol, but shorter than salmeterol. Picumeterol is the (R)-isomer of the racemic entity GR63411B, and picumeterol has been shown to be about 40 times more potent than the (S)-isomer (GR114744A) in various in vitro pharmacological models of beta2-agonist activity. Picumeterol is of potential value in the treatment of asthma and related diseases in man following inhalation administration. In the clinical studies, the bronchodilator potencies of picumeterol and GR 63411B were similar. However, both drugs were short-acting, which is at odds with their activity in vitro. These compounds display dissociation between bronchodilator activity and protection against methacholine-induced bronchoconstriction.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Kinetics and disposition of picumeterol in animals. | 1995 Sep |
|
Some pharmacodynamic aspects on long-acting beta-adrenoceptor agonists. | 1996 Jun |
|
Picumeterol: dissociation of improvement in lung function and reduction of airways hyperresponsiveness in asthmatics. | 1997 Feb |
|
Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β(2)-Adrenoceptor Agonists. | 2018 Jul |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:30:36 GMT 2023
by
admin
on
Fri Dec 15 16:30:36 GMT 2023
|
Record UNII |
0SUN4UF93Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 15 16:30:36 GMT 2023 , Edited by admin on Fri Dec 15 16:30:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2110947
Created by
admin on Fri Dec 15 16:30:36 GMT 2023 , Edited by admin on Fri Dec 15 16:30:36 GMT 2023
|
PRIMARY | |||
|
C76544
Created by
admin on Fri Dec 15 16:30:36 GMT 2023 , Edited by admin on Fri Dec 15 16:30:36 GMT 2023
|
PRIMARY | |||
|
CC-54
Created by
admin on Fri Dec 15 16:30:36 GMT 2023 , Edited by admin on Fri Dec 15 16:30:36 GMT 2023
|
PRIMARY | |||
|
10350952
Created by
admin on Fri Dec 15 16:30:36 GMT 2023 , Edited by admin on Fri Dec 15 16:30:36 GMT 2023
|
PRIMARY | |||
|
0SUN4UF93Y
Created by
admin on Fri Dec 15 16:30:36 GMT 2023 , Edited by admin on Fri Dec 15 16:30:36 GMT 2023
|
PRIMARY | |||
|
130641-37-1
Created by
admin on Fri Dec 15 16:30:36 GMT 2023 , Edited by admin on Fri Dec 15 16:30:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |